Improving Catalytic Efficiency and Changing Substrate Spectrum for Asymmetric Biocatalytic Reductive Amination

다국어 초록 (Multilingual Abstract)

With the advantages of biocatalytic method, enzymes have been excavated for the synthesis of chiral amino acids by the reductive amination of ketones, offering a promising way of producing pharmaceutical intermediates. In this work, a robust phenylalanine dehydrogenase (PheDH) with wide substrate spectrum and high catalytic efficiency was constructed through rational design and active-site-targeted, site-specific mutagenesis by using the parent enzyme from Bacillus halodurans. Active sites with bonding substrate and amino acid residues surrounding the substrate binding pocket, 49L-50G-51G, 74M,77K, 122G-123T-124D-125M, 275N, 305L and 308V of the PheDH, were identified. Noticeably, the new mutant PheDH (E113D-N276L) showed approximately 6.06-fold increment of kcat/Km in the oxidative deamination and more than 1.58-fold in the reductive amination compared to that of the wide type. Meanwhile, the PheDHs exhibit high capacity of accepting benzylic and aliphatic ketone substrates. The broad specificity, high catalytic efficiency and selectivity, along with excellent thermal stability, render these broad-spectrum enzymes ideal targets for further development with potential diagnostic reagent and pharmaceutical compounds applications.

참고문헌 (Reference)

1 Asano Y, "Thermostable phenylalanine dehydrogenase from a mesophilic Microbacterium sp. strain DM 86-1" 169 : 220-224, 1998

2 Abrahamson MJ, "The evolution of an amine dehydrogenase biocatalyst for the asymmetric production of chiral amines" 355 : 1780-1786, 2013

3 Arnold K, "The SWISSMODEL workspace : a web-based environment for protein structure homology modelling" 22 : 195-201, 2006

4 Yun H, "Synthesis of enantiomerically pure trans-(1R, 2R)-and cis-(1S, 2R)-1-amino-2-indanol by lipase and ω-transaminase" 93 : 391-395, 2006

5 Hanson RL, "Synthesis of allysine ethylene acetal using phenylalanine dehydrogenase from Thermoactinomyces intermedius" 26 : 348-358, 2000

6 ZN You QC, "Switching cofactor dependence of 7β-hydroxysteroid dehydrogenase for cost-effective production of ursodeoxycholic acid" 9 : 466-473, 2018

7 Kataoka K, "Site-directed mutagenesis of a hexapeptide segment involved in substrate recognition of phenylalanine dehydrogenase from Thermoactinomyces intermedius" 114 : 69-75, 1993

8 Brunhuber NM, "Rhodococcus L-phenylalanine dehydrogenase : kinetics, mechanism, and structural basis for catalytic specifity" 39 : 9174-9187, 2000

9 Chen R, "Redesigning secondary structure to invert coenzyme specificity in isopropylmalate dehydrogenase" 93 : 12171-12176, 1996

10 Helmchen G, "Phosphinooxazolines a new class of versatile, modular P, N-ligands for asymmetric catalysis" 33 : 336-345, 2000

11 Vanhooke JL, "Phenylalanine dehydrogenase from Rhodococcus sp. M4 : high-resolution X-ray analyses of inhibitory ternary complexes reveal key features in the oxidative deamination mechanism" 38 : 2326-2339, 1999

12 Woodley JM, "New opportunities for biocatalysis : making pharmaceutical processes greener" 26 : 321-327, 2008

13 Mihara H, "N-Methyl-l-amino acid dehydrogenase from Pseudomonas putida" 272 : 1117-1123, 2005

14 Iwasaki A, "Microbial synthesis of chiral amines by (R)-specific transamination with Arthrobacter sp. KNK168" 69 : 499-505, 2006

15 Constable DJ, "Key green chemistry research areas-a perspective from pharmaceutical manufacturers" 9 : 411-420, 2007

16 Hummel W, "Isolation and characterization of a bacterium possessing L-phenylalanine dehydrogenase activity" 137 : 47-52, 1984

17 Sekimoto T, "Involvement of conserved lysine 68 of Bacillus stearothermophilus leucine dehydrogenase in substrate binding" 269 : 7262-7266, 1994

18 Breuer M, "Industrielle Verfahren zur Herstellung von optisch aktiven Zwischenprodukten" 116 : 806-843, 2004

19 Breuer M, "Industrial methods for the production of optically active intermediates" 43 : 788-824, 2004

20 Bloom JD, "In the light of directed evolution : pathways of adaptive protein evolution" 106 : 9995-10000, 2009

21 Kataoka K, "Identification of active site lysyl residues of phenylalanine dehydrogenase by chemical modification with methyl acetyl phosphate combined with site-directed mutagenesis" 116 : 1370-, 1994

22 Moon K, "Glutamate Dehydrogenase : amino-acid sequence of the bovine enzyme and comparison with that from chicken liver" 69 : 1380-1383, 1972

23 Koszelewski D, "Formal asymmetric biocatalytic reductive amination" 47 : 9337-9340, 2008

24 Vick JE, "Evolutionary potential of(β/α)8-barrels : in vitro enhancement of a"new"reaction in the enolase superfamily" 44 : 11722-11729, 2005

25 Ye LJ, "Engineering of amine dehydrogenase for asymmetric reductive amination of ketone by evolving Rhodococcus phenylalanine dehydrogenase" 5 : 1119-1122, 2015

26 Chen S, "Efficient screening for new amino acid dehydrogenase activity : Directed evolution of Bacillus sphaericus phenylalanine dehydrogenase towards activity with an unsaturated non-natural amino acid" 142 : 127-134, 2009

27 Hoehne M, "Efficient asymmetric synthesis of chiral amines by combining transaminase and pyruvate decarboxylase" 9 : 363-365, 2008

28 Carter JL, "Directed evolution of a formate dehydrogenase for increased tolerance to ionic liquids reveals a new site for increasing the stability" 15 : 2710-2718, 2014

29 Xu JHg, X, "Development of an engineered ketoreductase with simultaneously improved thermostability and activity for making a bulky atorvastatin precursor" 9 : 147-153, 2018

30 Abrahamson MJ, "Development of an amine dehydrogenase for synthesis of chiral amines" 51 : 3969-3972, 2012

31 Drug Enforcement Administration, "Department of Justice. Establishment of drug codes for 26 substances" 78 (78): 664-, 2012

32 Mutti FG, "Conversion of alcohols to enantiopure amines through dualenzyme hydrogen-borrowing cascades" 349 : 1525-1529, 2015

33 Mcpherson MJ, "Complete nucleotide sequence of the Escherichia coli gdhA gene" 11 : 5257-5266, 1983

34 Nugent TC, "Chiral amine synthesis–recent developments and trends for enamide reduction, reductive amination, and imine reduction" 352 : 753-819, 2010

35 Höhne M, "Biocatalytic routes to optically active amines" 1 : 42-51, 2009

36 Savile CK, "Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture" 329 : 305-309, 2010

37 Sun H, "Biocatalysis for the synthesis of pharmaceuticals and pharmaceutical intermediates" 26 : 1275-1284, 2017

38 Pollard DJ, "Biocatalysis for pharmaceutical intermediates : the future is now" 25 : 66-73, 2007

39 Sheldon RA, "Biocatalysis engineering : the big picture" 46 : 2678-2691, 2017

40 Randell EW, "An automated enzymatic method on the Roche COBAS MIRA TM S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria" 29 : 133-138, 1996

41 Jarvo ER, "Amino acids and peptides as asymmetric organocatalysts" 58 : 2481-2495, 2002

42 Kuroda S, "Alanine dehydrogenases from two Bacillus species with distinct thermostabilities : molecular cloning, DNA and protein sequence determination, and structural comparison with other NAD(P)+-dependent dehydrogenases" 29 : 1009-1015, 1990

43 Wilks HM, "A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework" 242 : 1541-1544, 1988

44 Jiang W, "A novel serine hydroxymethyltransferase from Arthrobacter nicotianae : characterization and improving catalytic efficiency by rational design" 14 : 93-, 2014

45 Bommarius BR, "A novel chimeric amine dehydrogenase shows altered substrate specificity compared to its parent enzymes" 50 : 14953-14955, 2014

46 Ma SK, "A green-by-design biocatalytic process for atorvastatin intermediate" 12 : 81-86, 2010